“It was first understood as our main defense against opioid overdose,” Nguyen said. “The issue is that for some time, the FDA had not granted the approval of over-the-counter, non-prescription use of Naloxone because I think the standards for treating opioid overdoses were still being developed.”
Trending
- SLIDESHOW: Baylor vs. Louisiana Tech
- Bennett’s 4 touchdowns push Baylor past Louisiana Tech 36-19
- Baylor’s defense slowed down in win over LA Tech
- Last-second equalizer forces No. 12 Baylor soccer into draw with No. 9 West Virginia
- Old Dominion brings bright lights, classic country to Foster Pavilion
- No. 18 Baylor volleyball surges past UTEP behind 3rd set rally
- Review: Lizzy McAlpine explores connection with ‘Angel’
- Lariat TV News: September 18th, 2026

